Literature DB >> 2731169

Negative controls of cell proliferation: human prostate cancer cells and androgens.

C Sonnenschein1, N Olea, M E Pasanen, A M Soto.   

Abstract

LNCaP cells represent a useful tool to explore the mechanism of sex hormone action on cell proliferation in an "in culture-in animal" model. Results indicated that: (a) these cells were inhibited from proliferating for extended periods (up to 30 days) when placed in charcoal-dextran-stripped sera; they remained, however, viable because they proliferated when sex hormones were added to this medium; (b) the inhibitory effect of sera was reversed by the addition of 5 alpha-dihydrotestosterone at 3 x 10(-10) M, 17 beta-estradiol at 3 x 10(-8) M and higher concentrations, and progesterone at 3 x 10(-10) M and higher concentrations; (c) while the dose response to androgens was biphasic (i.e., 5 alpha-dihydrotestosterone at concentrations higher than 3 x 10(-10) M resulted in progressively lower cell yields), estrogens and progestagens exhibited a monophasic pattern; (d) these cells were exceedingly sensitive to the nutritional environment in which they grew; (e) while these cells have androgen receptors (68 fmol/mg protein; Kd = 2 x 10(-9) M), estrogen and progestagen receptors could not be detected by biochemical and immunocytochemical techniques; (f) tumors grew at the site of inoculation in castrated nude mice carrying 17 beta-estradiol and progesterone pellets and in intact male nude mice implanted with placebo pellets, while tumors did not grow in castrated nude mice implanted with a 5 alpha-dihydrotestosterone pellet. Taken together the data collected are compatible with the following conclusions: (a) the proliferative response in LNCaP cells seems not to be directly mediated by their intracellular androgen receptors; (b) plasma-borne trypsin-sensitive inhibitors of the proliferation of these cells (androcolyone I) appear to play a significant role in the proliferative event; (c) natural and synthetic androgens, estrogens, and progestagens cancelled the inhibition by charcoal-dextran-stripped human sera; (d) only androgens were able to trigger an inhibition of cell proliferation (shutoff effect) at concentrations higher than those that affected maximal cell yields (direct negative hypothesis); and (e) a faulty shutoff response is probably a crucial event for the tumorigenesis of these human prostate cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2731169

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

Review 1.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

2.  APRIN is a unique Pds5 paralog with features of a chromatin regulator in hormonal differentiation.

Authors:  Maricel Maffini; Viktoria Denes; Carlos Sonnenschein; Ana Soto; Peter Geck
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-12       Impact factor: 4.292

3.  Androgen receptor coregulators NOCR1, TIF2, and ARA70 may account for the hydroxyflutamide insensitivity of prostate cancer cells.

Authors:  Y Wang; J-Q Li; C Shao; C-H Shi; F Liu; Z-Y Yang; J-X Qiu; Y-M Li; Q Fu; W Zhang; W Xue; Y-H Lei; J-Y Gao; J-Y Wang; X-P Gao; J-L Yuan; T-Y Bao; Y-T Zhang
Journal:  Ir J Med Sci       Date:  2011-07-05       Impact factor: 1.568

4.  Glutamine Transporters Are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer.

Authors:  Mark A White; Chenchu Lin; Kimal Rajapakshe; Jianrong Dong; Yan Shi; Efrosini Tsouko; Ratna Mukhopadhyay; Diana Jasso; Wajahat Dawood; Cristian Coarfa; Daniel E Frigo
Journal:  Mol Cancer Res       Date:  2017-05-15       Impact factor: 5.852

Review 5.  Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; John Peterson Myers; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller
Journal:  Reprod Toxicol       Date:  2013-02-11       Impact factor: 3.143

6.  DHX15 is up-regulated in castration-resistant prostate cancer and required for androgen receptor sensitivity to low DHT concentrations.

Authors:  Yadong Xu; Qiong Song; Laura E Pascal; Mingming Zhong; Yibin Zhou; Jianhua Zhou; Fang-Ming Deng; Jiaoti Huang; Zhou Wang
Journal:  Prostate       Date:  2019-02-03       Impact factor: 4.104

Review 7.  Minireview: Endocrine Disruptors: Past Lessons and Future Directions.

Authors:  Thaddeus T Schug; Anne F Johnson; Linda S Birnbaum; Theo Colborn; Louis J Guillette; David P Crews; Terry Collins; Ana M Soto; Frederick S Vom Saal; John A McLachlan; Carlos Sonnenschein; Jerrold J Heindel
Journal:  Mol Endocrinol       Date:  2016-07-19

8.  Editorial: Centennial Celebration - An Interview With Dr Ana Soto on 25 Years of Research on Endocrine-Disrupting Chemicals.

Authors: 
Journal:  Mol Endocrinol       Date:  2016-08

9.  Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP.

Authors:  Oskar W Rokhlin; Agshin F Taghiyev; Natalya V Guseva; Rebecca A Glover; Peter M Chumakov; Julia E Kravchenko; Michael B Cohen
Journal:  Oncogene       Date:  2005-10-13       Impact factor: 9.867

Review 10.  Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption.

Authors:  Laura N Vandenberg; Maricel V Maffini; Carlos Sonnenschein; Beverly S Rubin; Ana M Soto
Journal:  Endocr Rev       Date:  2008-12-12       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.